The representative, In effort with various operational counterparts within the company and with external suppliers/vendors, Will ensure therapeutic strategy development and the clinical and operational enactment of company sponsored studies, investigator initiated studies and post marketing risk management research programs, in the course of in sourced, Outsourced or matrixed links. the consumer will focus on Phase II Phase IV studies, Post marketing risk management research programs and IIS trials to ensure strategic level plans are executed in a timely and compliant fashion for accomplishment of Medical Affairs' research goals. Manage and be in charge of budgets for multiple therapeutic areas across the portfolio.
from the
Who watched through the guardrail
December 27th, 2014 at 03:12 pm